Immunotherapy and targeted therapy of advanced non-small cell lung carcinoma: Treatment benefits and cost in an unselected real-life population

About the project

  • Project period: 01.07.2021 - 31.12.2024 (Concluded)
  • Coordinating Institution: Norwegian Institute of Public Health
  • Project Manager:
    • Bettina Kulle Andreassen, The Cancer Registry of Norway, Norwegian Institute of Public Health
  • Project Participants:
    • Helga Helseth Hektoen, The Cancer Registry of Norway, Norwegian Institute of Public Health
    • Giske Ursin, The Cancer Registry of Norway, Norwegian Institute of Public Health
Published | Last update